Clinical Trial Update: Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B [Phase 4]

View source ↗

Summary

Phase 4 trial investigating spironolactone to prevent electrolyte abnormalities in patients receiving amphotericin B was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections

Drugs mentioned

• Amphotericin B (Amphotericin B)
• Spironolactone (spironolactone)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Patients With Fungic Infections | Phase 4 | Status: TERMINATED